Navigation Links
Amylin Pharmaceuticals Reports 2007 Financial Results
Date:1/28/2008

nd enhance the profile of exenatide once weekly, the advancement of our obesity program, and continued investments in discovery research."

Quarter ended December 31, 2007

Net product sales of $194.7 million for the quarter include sales of $176.3 million for BYETTA(R) (exenatide) injection and $18.4 million for SYMLIN(R) (pramlintide acetate) injection. This compares to net product sales of $150.6 million, consisting of $137.0 million for BYETTA and $13.6 million for SYMLIN for the same period in 2006.

Revenue under collaborative agreements was $27.3 million for the quarter ended December 31, 2007, compared to $12.8 million for the same period in 2006. The increase reflects higher cost-sharing payments from Lilly and Company to equalize development expenses for BYETTA and exenatide once weekly.

The Company's results for quarter ended December 31, 2007 includes $17 million in full year non-cash expense associated with the adoption of an ESOP of which $10 million is included in selling, general and administrative expenses and $7 million is included in research and development expenses. The adoption of the ESOP represents a change in the composition of the Company's equity compensation.

Selling, general and administrative expenses increased to $122.4 million for the quarter ended December 31, 2007, compared to $89.6 million for the same period in 2006. The increase primarily reflects increased promotional expenses for BYETTA and SYMLIN and increased business infrastructure to support the Company's growth.

Research and development expenses increased to $83.9 million for the quarter ended December 31, 2007, compared to $66.2 million for the same period in 2006. The increase primarily reflects costs associated with the development of exenatide once weekly, including manufacturing scale-up.

Collaborative profit sharing, which represents Lilly's share of the gross margin for BYETTA, was $78.6 million for the quarter ended Dec
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Xenome Enters Into Joint Research Collaboration to Discover Novel Peptide Therapeutics with Amylin Pharmaceuticals
2. Amylin Pharmaceuticals to Present at Research & Development Day
3. Amylin Pharmaceuticals to Webcast Conference Call
4. Amylin Pharmaceuticals to Webcast Third Quarter Results
5. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
6. MiddleBrook Pharmaceuticals to Raise $21 Million Through Private Placement of Common Equity
7. Acura Pharmaceuticals, Inc. Announces Appointment of George K. Ross as Director
8. Wyeth and Teva Pharmaceuticals Extend the Standstill Period Relating to Tevas Launch of Generic Pantoprazole
9. Bradley Pharmaceuticals Announces Filing of Definitive Proxy Statement for Special Meeting of Stockholders to Approve Merger With Nycomed
10. MAP Pharmaceuticals Reaches Agreement with FDA on Special Protocol Assessment for MAP0004 Phase 3 Clinical Trial in Patients With Migraine
11. Access Licenses MuGard(TM) to RHEI Pharmaceuticals, a Leading Specialty Pharmaceutical Company for Distribution in China and Certain Other Southeast Asian Countries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... live near green spaces deliver babies with significantly ... "Green Spaces and Adverse Pregnancy Outcomes" published in ... , A team of researchers from Israel and ... evaluated nearly 40,000 single live births from a ... determine the impact of green surroundings during pregnancy ...
(Date:7/28/2014)... July 28, 2014 With California in ... is welcome news that a fire blanket ... protection is under development by SunSeeker Enterprises, Inc. The ... protect spacecraft from the extreme heat of re-entry into ... firefighters and homes. , “Our firefighters routinely lay their ...
(Date:7/28/2014)... The report “Industrial Enzymes Market ... Beverages, Cleaning Agents, Bio-Fuel, Animal Feed), & Geography ... and segments the global industrial enzymes market with ... industrial enzymes. It also identifies driving and restraining ... analysis of trends, opportunities, burning issues, winning imperatives, ...
(Date:7/28/2014)... The University of Texas Health Science Center at San Antonio, ... combination of pills that cures 9 of 10 hepatitis C ... with or without ribavirin, cured 93 percent of patients in ... the study published today in The Lancet . ... Eric Lawitz, M.D., clinical professor in the School of Medicine ...
(Date:7/28/2014)... Recent research has shown the cumulative impact of ... lead to a range of health problems including obesity, ... desk, or an adjustable sit-to-stand desk, commonly leads to ... to a seated position. , The new Standing ... leg pain and fatigue while working upright. These durable ...
Breaking Medicine News(10 mins):Health News:Revolutionary Fire Blanket Offers Over 200 Percent More Fire Protection to Firefighters and Homes 2Health News:Industrial Enzymes Market Worth $5,987.5 Million by 2018 - Report by MarketsandMarkets 2Health News:Industrial Enzymes Market Worth $5,987.5 Million by 2018 - Report by MarketsandMarkets 3Health News:Industrial Enzymes Market Worth $5,987.5 Million by 2018 - Report by MarketsandMarkets 4Health News:New pill regimens published in The Lancet cure hardest-to-treat hepatitis C patients 2Health News:New Standing Desk Anti-fatigue Mats from Martinson-Nicholls Reduce Leg Fatigue and Discomfort Working at Standing and Sit-to-Stand Desks 2
... contributed by our work is its relevance to population ... discover survival related to cancer in a more precise ... and researcher in the Epidemiology Service of the Department ... The investigation, which has been published in the ...
... "happy families are all alike; every unhappy family is unhappy ... unhappy families, in fact, are unhappy in two distinct ways. ... a host of specific difficulties for children during their early ... for children as they enter school, or they can be ...
... international bans, more than 250,000 children fight as soldiers ... them in Africa. Two new studies explored how these ... to successful adaptation, the studies found, was the characteristics ... In the first study, researchers found that former child ...
... Anderson Cancer Center remains the leading hospital in the nation for ... "Best Hospitals" survey published by U.S. News & World Report. ... MD Anderson has ranked number one in the annual listing. Since ... of the top two cancer hospitals in the United States. ...
... HealthDay Reporter , WEDNESDAY, July 14 (HealthDay ... and rheumatoid arthritis shows promise as an option to ... blood vessels, according to two new studies. The ... current standard, cyclophosphamide, in treating antineutrophil cytoplasmic antibody ...
... , TORONTO, ON On the eve of the world,s ... review shows many people wouldn,t get inoculated against HIV even ... published in this month,s edition of the journal AIDS ... the University of Toronto,s Factor-Inwentash Faculty of Social Work. Newman ...
Cached Medicine News:Health News:The probability of surviving nine types of cancer is analyzed 2Health News:Behavior problems in school linked to 2 types of families 2Health News:Behavior problems in school linked to 2 types of families 3Health News:Studies explore effects of war on former child soldiers 2Health News:Studies explore effects of war on former child soldiers 3Health News:Studies explore effects of war on former child soldiers 4Health News:MD Anderson keeps No. 1 cancer ranking in US News & World Report annual survey 2Health News:MD Anderson keeps No. 1 cancer ranking in US News & World Report annual survey 3Health News:Rare Blood Vessel Disease Could Have New Treatment Option 2Health News:Rare Blood Vessel Disease Could Have New Treatment Option 3Health News:Future HIV vaccines: If we build it, will they come? 2
(Date:7/28/2014)... 28, 2014  ALPHAEON Corporation ® ... and subsidiary of Strathspey Crown Holdings ... Nutriceuticals (PRN) ® , a leading developer ... for dry eye and macular degeneration, ... worth up to $55M. ...
(Date:7/28/2014)... , SINGAPORE, and TOKYO , July ... that it has appointed Roger Crystal , MD ... recently served in the Global Business Development Product Acquisition ... "Roger,s experience in developing business strategy and partnerships ... as we continue to partner with biotechnology and pharmaceutical ...
(Date:7/28/2014)... MURRAY HILL and NEW PROVIDENCE, ... management and engineering professionals are invited to meet with ... Conference and Technical Exhibition to be held at McCormick ... August 3-6. "Hospitals demand nothing less ... said Mark Sanda , Linde,s Healthcare Segment manager. ...
Breaking Medicine Technology:ALPHAEON Acquires PRN, A Leading Specialty Nutriceutical Company 2ALPHAEON Acquires PRN, A Leading Specialty Nutriceutical Company 3ImaginAb Appoints Roger Crystal, MD as Vice President of Business Development 2Linde's Healthcare division to display new Hospital Services platform at the national ASHE Conference in Chicago 2
... Calif., April 2, 2012 No matter the advances that ... are suffering with tooth damage and decay every single day. According ... percent of all adults as well as 16 percent of ... the integrity and appearance of smiles, the most trusted ...
... Calif., April 2, 2012 Fortis Healthcare, ... hospitals across the country, and Masimo (NASDAQ: ... technology supplier agreement that allows Fortis hospitals access to ... pulse oximetry and noninvasive, continuous patient monitoring solutions. ...
Cached Medicine Technology:Northridge Cosmetic Dentists, Dr. Michel Elyson and Dr. Ramin Assili, are Now Offering Advanced Tooth Colored Restorations to Restore Smiles 2Fortis Healthcare Signs Agreement Giving India's Fastest-Growing Hospital Chain Access to Masimo's State-of-the-Art Noninvasive Patient Monitoring Solutions 2Fortis Healthcare Signs Agreement Giving India's Fastest-Growing Hospital Chain Access to Masimo's State-of-the-Art Noninvasive Patient Monitoring Solutions 3Fortis Healthcare Signs Agreement Giving India's Fastest-Growing Hospital Chain Access to Masimo's State-of-the-Art Noninvasive Patient Monitoring Solutions 4Fortis Healthcare Signs Agreement Giving India's Fastest-Growing Hospital Chain Access to Masimo's State-of-the-Art Noninvasive Patient Monitoring Solutions 5Fortis Healthcare Signs Agreement Giving India's Fastest-Growing Hospital Chain Access to Masimo's State-of-the-Art Noninvasive Patient Monitoring Solutions 6Fortis Healthcare Signs Agreement Giving India's Fastest-Growing Hospital Chain Access to Masimo's State-of-the-Art Noninvasive Patient Monitoring Solutions 7Fortis Healthcare Signs Agreement Giving India's Fastest-Growing Hospital Chain Access to Masimo's State-of-the-Art Noninvasive Patient Monitoring Solutions 8
... Finn Revision Knee System ... distal femoral replacement options. The ... Finn Rotating Hinge Knee, promotes ... function and is designed for ...
The Advance stemmed medial-pivot knee is a revision knee that provides unique and competitive features....
... The NexGen Legacy LCCK Femoral Component ... additional prosthetic stabilization due to inadequate ... and require augmentation and/or stem extensions ... NexGen LCCK is available with a ...
The Duracon system provides superb articular conformity throughout the range of motion, reducing contact stresses generally associated with wear....
Medicine Products: